Growth Investor27
reacted to
$Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics Non Statin Multi-Billion future Drug NEXLIZET has Reversed Type2 Diabetes After Removing Statin Drug to Lower Bad Cholesterol
$Esperion Therapeutics (ESPR.US)$
https://www.youtube.com/watch?v=DMW-BtT7WWE
From YouTube
Latest is Esperion has moved it's earnings date forward from scheduled 11/11 to 11/05. We know speculation is that Esperion might be selling some or all of the rights to it's Cholesterol d...
$Esperion Therapeutics (ESPR.US)$
https://www.youtube.com/watch?v=DMW-BtT7WWE
From YouTube
Latest is Esperion has moved it's earnings date forward from scheduled 11/11 to 11/05. We know speculation is that Esperion might be selling some or all of the rights to it's Cholesterol d...
+16
11
1
$Esperion Therapeutics (ESPR.US)$ The recent analyst note from Jeff sugest Esperion might sell the entire rights for Bempedoic Acid. Fair valuation on the rights would be above $1.5 billion, based on future milestones $900 million, future royalties & patents, the current formulation patent has exp date Dec 2031. The potential yearly sales in the U.S could reach $4 billion by 2027.
Esperion could also partner in the U.S .
Keep an...
Esperion could also partner in the U.S .
Keep an...
1
1
Growth Investor27
reacted to
#1 Stock To Invest in for 10X+Upside Is ESPR. $AMD From $3 To $100+ Now This Investor BETS $22M In ESPR, Predicts this $2 stock will be $30 to $50 in 3 years If not bought out soon.
Exciting NEWS Today Oct 11th, MILOS study highlights potential of bempedoic acid to advance dyslipidemia treatment: GlobalData
Daiichi Sankyo has recently announced the final two-year follow-up data from the German cohort ...
Exciting NEWS Today Oct 11th, MILOS study highlights potential of bempedoic acid to advance dyslipidemia treatment: GlobalData
Daiichi Sankyo has recently announced the final two-year follow-up data from the German cohort ...
+14
21
1
Growth Investor27
reacted to
An Investment Now In This Company Should Return 10 X Your Money.
$Esperion Therapeutics (ESPR.US)$Is going to be one of those stocks people wish they loaded up on, but I highly Suggest you buy some now. This isn't a Pump article. Read the facts & decide for yourself. People mostly miss out the the explosive growth curve and ...
$Esperion Therapeutics (ESPR.US)$Is going to be one of those stocks people wish they loaded up on, but I highly Suggest you buy some now. This isn't a Pump article. Read the facts & decide for yourself. People mostly miss out the the explosive growth curve and ...
+15
17
Growth Investor27
liked and commented on
Expect PLUG Power Short Squeeze 293 Million Shares Short. Plug has A.i Energy Advantage
PLUG Power Stock Could Soon Double SHORT Squeeze To $4. A.i Power Based Investment
$Plug Power (PLUG.US)$ PLUG beaten down by short sellers while the company has now set itself up to start generating substantial retur...
PLUG Power Stock Could Soon Double SHORT Squeeze To $4. A.i Power Based Investment
$Plug Power (PLUG.US)$ PLUG beaten down by short sellers while the company has now set itself up to start generating substantial retur...
4
2
Growth Investor27
reacted to and commented on
PLUG Power Stock Could Soon Double SHORT Squeeze To $4. A.i Power Based Investment
$Plug Power (PLUG.US)$ PLUG has beaten down by short sellers while the company has now set itself up to start generating substantial returns in 2025. The current stock price is $2.07 and trades below it's book value of $3.79. Short sellers hold 31% of the public float, with a record 293 million shares. An ultimate short SQUEEZ...
$Plug Power (PLUG.US)$ PLUG has beaten down by short sellers while the company has now set itself up to start generating substantial returns in 2025. The current stock price is $2.07 and trades below it's book value of $3.79. Short sellers hold 31% of the public float, with a record 293 million shares. An ultimate short SQUEEZ...
16
6
$Plug Power (PLUG.US)$ currently at $2.12 PLUG is trading below fair value. Book value is $3.79 & Growth ability is tremendous. This energy sector play is must have in the speculative part of your portfolio. Analysts need to get behind this company.
1
Growth Investor27
liked
$Esperion Therapeutics (ESPR.US)$Is going to be one of those stocks people wish they loaded up on, but I highly Suggest you buy some now. This isn't a Pump article. Read the facts & decide for yourself. People mostly miss out the the explosive growth curve and Esperion is just getting started. Read the facts shown below why Esperion is HUGELY Undervalued with it's unique drugs now available in the most prescribed drugs in the enti...
+15
22
7
Growth Investor27
liked
$Esperion Therapeutics (ESPR.US)$
Esperion EU Partner Reports Final Real-World Results from MILOS German Cohort Demonstrating Strong Increase in LDL-C Goal Achievement With Addition of Bempedoic Acid
Esperion EU Partner Reports Final Real-World Results from MILOS German Cohort Demonstrating Strong Increase in LDL-C Goal Achievement With Addition of Bempedoic Acid
2
Growth Investor27
reacted to and commented on
Buying Esperion ESPR Now is Like Buying NVIDIA, TESLA,META,AMD,AAPL Before their share prices Rocketed 3000%+.
$Esperion Therapeutics (ESPR.US)$Is going to be one of those stocks people wish they loaded up on. This isn't a Pump article. Read the facts & decide for yourself. People mostly miss out the the explosive growth curve. Esperion...
$Esperion Therapeutics (ESPR.US)$Is going to be one of those stocks people wish they loaded up on. This isn't a Pump article. Read the facts & decide for yourself. People mostly miss out the the explosive growth curve. Esperion...
+15
20
3